Atypical presentation of type 1 neovascularization with aneurysmal dilations in a young female.

Autor: Zamorano M; Department of Ophthalmology, University Hospital Guadalajara, Guadalajara, Spain. Electronic address: margazamo@gmail.com., Puerto B; Department of Ophthalmology, Ramon y Cajal University Hospital, Madrid, Spain., Carceller J; Department of Ophthalmology, Ramon y Cajal University Hospital, Madrid, Spain., González-López JJ; Department of Ophthalmology, Ramon y Cajal University Hospital, Madrid, Spain., Figueroa MS; Department of Ophthalmology, Ramon y Cajal University Hospital, Madrid, Spain., Muñoz-Negrete FJ; Department of Ophthalmology, Ramon y Cajal University Hospital, Madrid, Spain.
Jazyk: angličtina
Zdroj: Archivos de la Sociedad Espanola de Oftalmologia [Arch Soc Esp Oftalmol (Engl Ed)] 2024 Dec; Vol. 99 (12), pp. 562-565. Date of Electronic Publication: 2024 Oct 17.
DOI: 10.1016/j.oftale.2024.10.004
Abstrakt: Type 1 Neovascularization with Aneurysmal Dilations (N1a), is a retinal disorder characterized by choroidal vascular abnormalities. Clinically, it is characterized by an exudative maculopathy with multiple recurrent serosanguineous pigment epithelial detachments. This disease is more frequent in women aged 55-65 years. However, we present an exceptional case of N1a in a 26-year-old woman, who responded favorably to Aflibercept. To our knowledge, this is the first reported case of a young female patient under 30 with N1a. The patient has responded very favourably to anti-VEGF therapy with three intravitreal injections of Aflibercept. This being the reason for we provide an update on anti-VEGF therapeutic options for N1a.
Competing Interests: Declaration of competing interest None declared.
(Copyright © 2024 Sociedad Española de Oftalmología. Published by Elsevier España, S.L.U. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: